Higher anti-TNF drug levels could improve radiological outcomes in perianal fistulising Crohn’s disease patients, according to a study by Australian gastroenterologists. A review of 193 Crohn’s perianal fistula patients on infliximab or adalimumab showed those with radiological healing or remission had higher median drug levels than patients with active disease. At median 2.5 and 2.1 ...
Higher anti-TNF drug levels linked to better radiological outcomes in CD patients
By Natasha Doyle
25 Aug 2021